Mergers & Acquisitions ·
On June 29, 2026, shareholders approved the acquisition of 80% to 100% of Psyga Bio Ltd. via the issuance of shares…
XTLBXtl Biopharmaceuticals Ltd
On June 29, 2026, shareholders approved the acquisition of 80% to 100% of Psyga Bio Ltd. via the issuance of shares and milestone warrants. Shareholders also approved a private placement of up to $1,500,000 from Alexander Rabinovitch and other investors, conditional upon the acquisition. Additionally, the company's authorized share capital will increase by 2,900,000,000 shares to a total of 5,800,000,000 ordinary shares. BARZILY & CO. C.P.A was appointed as the independent registered public accounting firm for the year ending December 31, 2025. XTL Biopharmaceuticals Ltd. is a biopharmaceutical company focused on developing medical treatments.